DE69433999D1 - Entzündungshemmende peptide - Google Patents

Entzündungshemmende peptide

Info

Publication number
DE69433999D1
DE69433999D1 DE69433999T DE69433999T DE69433999D1 DE 69433999 D1 DE69433999 D1 DE 69433999D1 DE 69433999 T DE69433999 T DE 69433999T DE 69433999 T DE69433999 T DE 69433999T DE 69433999 D1 DE69433999 D1 DE 69433999D1
Authority
DE
Germany
Prior art keywords
peptides
inflammatory peptides
peptide
pharmaceutical compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69433999T
Other languages
English (en)
Other versions
DE69433999T2 (de
Inventor
David F Counts
Ronald G Duff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curative Technologies Inc
Original Assignee
Curative Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curative Technologies Inc filed Critical Curative Technologies Inc
Publication of DE69433999D1 publication Critical patent/DE69433999D1/de
Application granted granted Critical
Publication of DE69433999T2 publication Critical patent/DE69433999T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69433999T 1993-06-18 1994-06-17 Entzündungshemmende peptide Expired - Lifetime DE69433999T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80371 1987-07-31
US8037193A 1993-06-18 1993-06-18
PCT/US1994/006888 WO1995000543A1 (en) 1993-06-18 1994-06-17 Anti-inflammatory peptides

Publications (2)

Publication Number Publication Date
DE69433999D1 true DE69433999D1 (de) 2004-10-21
DE69433999T2 DE69433999T2 (de) 2005-09-22

Family

ID=22156955

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433999T Expired - Lifetime DE69433999T2 (de) 1993-06-18 1994-06-17 Entzündungshemmende peptide

Country Status (7)

Country Link
EP (1) EP0714404B1 (de)
JP (1) JP3645905B2 (de)
AT (1) ATE276272T1 (de)
AU (1) AU7209594A (de)
CA (2) CA2568107C (de)
DE (1) DE69433999T2 (de)
WO (1) WO1995000543A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69635205T2 (de) * 1995-07-10 2006-01-26 Asahi Medical Co. Ltd. Extrakorporaler blutkreislauf für die heilung entzündlicher krankheiten
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
CA2698691A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
EP2229951A1 (de) 2009-03-08 2010-09-22 Stichting Katholieke Universiteit Verfahren zur Behandlung oder Vorbeugung von systemischer Sklerose
CN112759634B (zh) * 2021-01-21 2022-04-08 浙江辉肽生命健康科技有限公司 具有氨基酸结构feyieenky的生物活性肽及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5480869A (en) * 1990-01-09 1996-01-02 The Regents Of The University Of California Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
KR100204400B1 (ko) * 1990-12-21 1999-06-15 로날드 지. 더프 맥관형성 펩티드
US5482930A (en) * 1993-06-09 1996-01-09 The Regents Of The University Of California Anti-inflammatory composition and method with des-Tyr dynorphin and analogues

Also Published As

Publication number Publication date
JP3645905B2 (ja) 2005-05-11
JPH09501415A (ja) 1997-02-10
EP0714404A1 (de) 1996-06-05
EP0714404A4 (de) 1999-02-10
AU7209594A (en) 1995-01-17
WO1995000543A1 (en) 1995-01-05
CA2568107A1 (en) 1995-01-05
DE69433999T2 (de) 2005-09-22
EP0714404B1 (de) 2004-09-15
CA2165418C (en) 2007-03-13
CA2165418A1 (en) 1994-12-19
CA2568107C (en) 2011-06-14
ATE276272T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
ID17863A (id) Komposisi-komposisi farmasi yang terdiri dari siklosporin
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
SE9404115L (sv) Salter av peptider med karboxiterminerade polyestrar
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
HK1025737A1 (en) Treatment of multiple sclerosis through ingestion of copolymer-1
ATE245977T1 (de) Therapeutische substituierte guanidine
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
NO980296L (no) Forbedrede terapeutiske midler
ATE276272T1 (de) Entzündungshemmende peptide
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9400072A (es) Agentes antiinflamatorios derivados de difluoropentapeptido.
IT1277338B1 (it) Composizioni farmaceutiche di ciclosporina o altre sostanze peptidiche
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
GR1002385B (el) Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν.
IT1270976B (it) Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono
ITMI922332A0 (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR1100310A (pt) Peptìdeo, composto e composição farmacêutica
ITMI930311A0 (it) Composizioni farmeceutiche di derivati amminoacidi
ITMI920368A1 (it) Composizioni farmaceutiche di derivati amminoacidi
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
ITMI911930A1 (it) Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition